Utilizing RNA interference to enhance cancer drug discovery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Utilizing RNA interference to enhance cancer drug discovery

Published:2007-07 Issue:7 Volume:6 Page:556-568
ISSN:1474-1776
Container-title:Nature Reviews Drug Discovery
language:en
Short-container-title:Nat Rev Drug Discov

Author:

Iorns Elizabeth,Lord Christopher J.,Turner Nicholas,Ashworth Alan

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmacology,General Medicine

Link

http://www.nature.com/articles/nrd2355.pdf

Reference66 articles.

1. Collins, I. & Workman, P. New approaches to molecular cancer therapeutics. Nature Chem. Biol. 2, 689–700 (2006).

2. Kamb, A., Wee, S. & Lengauer, C. Why is cancer drug discovery so difficult? Nature Rev. Drug Discov. 6, 115–120 (2007).

3. Pan, Q. et al. Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy. Cancer Res. 65, 8366–8371 (2005).

4. Horvath, S. et al. Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc. Natl Acad. Sci. USA 103, 17402–17407 (2006).

5. Zhang, Z., Jiang, G., Yang, F. & Wang, J. Knockdown of mutant K-ras expression by adenovirus-mediated siRNA inhibits the in vitro and in vivo growth of lung cancer cells. Cancer Biol. Ther. 5, 1481–1486 (2006).

Cited by 227 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trawling the Genome: Drug Target Identification in the Postgenomic Era;Drugs from Nature: Targets, Assay Systems and Leads;2024

2. Cancer Precision Drug Discovery Using Big Data and Artificial Intelligence Technologies;Research Anthology on Bioinformatics, Genomics, and Computational Biology;2023-12-29

3. PARP inhibitors enhance reovirus-mediated cell killing through the death-inducing signaling complex (DISC) with an associated NF-κB-regulated immune response;2023-12-22

4. miR-92a-3p regulates cisplatin-induced cancer cell death;Cell Death & Disease;2023-09-13

5. Small interference (RNAi) technique: Exploring its clinical applications, benefits and limitations;European Journal of Clinical Investigation;2023-06-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3